SHANGHAI NEW WORLD CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.84 CNY | -0.51% |
|
-9.88% | -16.69% |
| Sales 2022 | 850M 117M | Sales 2023 | 1.13B 157M | Capitalization | 4.53B 626M |
|---|---|---|---|---|---|
| Net income 2022 | -52M -7.18M | Net income 2023 | 31M 4.28M | EV / Sales 2022 | 4.35 x |
| Net cash position 2022 | 1.24B 172M | Net cash position 2023 | 1.39B 193M | EV / Sales 2023 | 2.77 x |
| P/E ratio 2022 |
-95.5
x | P/E ratio 2023 |
140
x | Employees | 1,203 |
| Yield 2022 |
0.39% | Yield 2023 |
0.43% | Free-Float | 47.69% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.51% | ||
| 1 week | -9.88% | ||
| Current month | -6.41% | ||
| 1 month | -8.75% | ||
| 3 months | -13.61% | ||
| 6 months | -15.36% | ||
| Current year | -16.69% |
1 week
5.70
6.45
1 month
5.706.78
Current year
5.308.46
1 year
5.308.46
3 years
5.3010.50
5 years
5.3015.95
10 years
5.3024.07
| Managers | Title | Age | Since |
|---|---|---|---|
Jia Ping Xu
CEO | Chief Executive Officer | 68 | - |
Wen Hua Wang
DFI | Director of Finance/CFO | 55 | 14-06-29 |
Yu Guo
PRN | Corporate Officer/Principal | 49 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jia Ping Xu
CEO | Chief Executive Officer | 68 | - |
Dong Ye
BRD | Director/Board Member | 53 | - |
Wei Li
SEC | Corporate Secretary | 48 | 14-06-27 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 5.84 | -0.51% | 3,507,725 |
| 24-04-18 | 5.87 | -1.34% | 3,952,935 |
| 24-04-17 | 5.95 | +4.02% | 4,500,100 |
| 24-04-16 | 5.72 | -6.84% | 7,511,066 |
| 24-04-15 | 6.14 | -5.25% | 9,671,614 |
End-of-day quote Shanghai S.E., April 18, 2024
More quotes
Shanghai New World Co Ltd is a China-based company mainly engaged in department store retail enterprises integrating modern department stores, tourism, leisure and entertainment comprehensive consumption. The Company operates its businesses through four segments. The Commercial segment is principally engaged in department store retail. The Pharmaceutical Industry segment is mainly engaged in the sales of various types of chinese medicinal materials, chinese patent medicines, western medicines, ginseng and antler supplements, nutritional health products and medical equipment. The Hotel Services segment is principally engaged in the operation of Radisson brand hotels managed by Radisson Hotel Group. The Company is also engaged in other businesses segment. The Company mainly operates its businesses in the domestic market.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -16.69% | 522M | |
| +24.60% | 654B | |
| +24.08% | 552B | |
| -5.63% | 356B | |
| +15.37% | 319B | |
| +7.38% | 295B | |
| +3.26% | 211B | |
| +0.78% | 206B | |
| -9.16% | 197B | |
| -9.69% | 147B |
- Stock Market
- Equities
- 600628 Stock
